STVN
STVN
IT0005452658
Stevanato Group S.p.A.
Loading chart...

Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Latest News

Related stocks

CTEC.L
CTEC.L • United Kingdom
CONVATEC GROUP PLC ORD 10P
220 GBp
5.58B USD 1Y -11.3%
YPSN.SW
YPSN.SW • Switzerland
YPSOMED HLDG
362.2 CHF
5.74B USD 1Y +6.9%
OBCK.DE
OBCK.DE • Germany
Ottobock SE & Co. KGaA I
53.2 EUR
3.81B USD
1SXP.DE
1SXP.DE • Germany
SCHOTT Pharma AG & Co. KGaA I
23.5 EUR
3.97B USD 1Y +20%
FIE.DE
FIE.DE • Germany
Fielmann Group AG I
37.35 EUR
3.51B USD 1Y -25.6%
TECN.SW
TECN.SW • Switzerland
TECAN GROUP AG N
235 CHF
3.49B USD 1Y +55.4%
SKAN.SW
SKAN.SW • Switzerland
SKAN N
70.7 CHF
1.92B USD 1Y +22.5%
SFL.MI
SFL.MI • Italy
SAFILO GROUP
1.85 EUR
806.23M USD 1Y +4.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
49.6% p.a.
Max Drawdown (5Y)
-62.2%
Sharpe Ratio (5Y)
-0.14
Beta Factor
0.78
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (49.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -62.2% in the extended horizon.
ende